☰

Paula D. Bos, Ph.D. - Publications

Affiliations: 
2009 Weill Cornell Medical College, New York, NY, United States 
Area:
Oncology, Cell Biology, Biostatistics Biology
Tree Info Similar researchers PubMed Report error

25/40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Bos P, van den Brekel MWM, Taghavi M, Gouw ZAR, Al-Mamgani A, Waktola S, J W L Aerts H, Beets-Tan RGH, Castelijns JA, Jasperse B. Largest diameter delineations can substitute 3D tumor volume delineations for radiomics prediction of human papillomavirus status on MRI's of oropharyngeal cancer. Physica Medica : Pm : An International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (Aifb). 101: 36-43. PMID 35882094 DOI: 10.1016/j.ejmp.2022.07.004  0.304
2022 Sanon S, Bos PD. In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells. Journal of Visualized Experiments : Jove. PMID 35815973 DOI: 10.3791/64002  0.508
2022 Bos P, van den Brekel MWM, Taghavi M, Gouw ZAR, Al-Mamgani A, Waktola S, Aerts HJWL, Beets-Tan RGH, Castelijns JA, Jasperse B. Simple delineations cannot substitute full 3d tumor delineations for MR-based radiomics prediction of locoregional control in oropharyngeal cancer. European Journal of Radiology. 148: 110167. PMID 35086005 DOI: 10.1016/j.ejrad.2022.110167  0.342
2021 Tyutyunyk-Massey L, Sun Y, Dao N, Ngo H, Dammalapati M, Vaidyanathan A, Singh M, Haqqani S, Haueis J, Finnegan R, Xiaoyan D, Kirberger S, Bos P, Bandyopadhyay D, Pomerantz W, et al. Autophagy Dependent Sensitization of Triple Negative Breast Cancer Models to Topoisomerase II Poisons by Inhibition of The Nucleosome Remodeling Factor. Molecular Cancer Research : McR. PMID 33811160 DOI: 10.1158/1541-7786.MCR-20-0743  0.349
2020 Clark NM, Martinez LM, Murdock S, deLigio JT, Olex AL, Effi C, Dozmorov MG, Bos PD. Regulatory T Cells Support Breast Cancer Progression by Opposing IFN-γ-Dependent Functional Reprogramming of Myeloid Cells. Cell Reports. 33: 108482. PMID 33296659 DOI: 10.1016/j.celrep.2020.108482  0.473
2020 Alhudaithi SS, Almuqbil RM, Zhang H, Bielski ER, Du W, Sunbul FS, Bos PD, da Rocha SRP. Local Targeting of Lung-Tumor-Associated Macrophages with Pulmonary Delivery of a CSF-1R Inhibitor for the Treatment of Breast Cancer Lung Metastases. Molecular Pharmaceutics. PMID 33170724 DOI: 10.1021/acs.molpharmaceut.0c00983  0.391
2020 Valiente M, Van Swearingen AED, Anders CK, Bairoch A, Boire A, Bos PD, Cittelly DM, Erez N, Ferraro GB, Fukumura D, Gril B, Herlyn M, Holmen SL, Jain RK, Joyce JA, et al. Brain Metastasis Cell Lines Panel: a public resource of organotropic cell lines. Cancer Research. PMID 32641416 DOI: 10.1158/0008-5472.Can-20-0291  0.576
2020 Du W, Bos PD. Tracing bone marrow-derived microglia in brain metastatic tumors. Methods in Enzymology. 635: 95-110. PMID 32122556 DOI: 10.1016/Bs.Mie.2019.08.017  0.428
2019 Martinez LM, Robila V, Clark NM, Du W, Idowu MO, Rutkowski MR, Bos PD. Regulatory T Cells Control the Switch From to Invasive Breast Cancer. Frontiers in Immunology. 10: 1942. PMID 31555258 DOI: 10.3389/Fimmu.2019.01942  0.563
2019 Buchta Rosean C, Bostic RR, Ferey JCM, Feng TY, Azar FN, Tung KS, Dozmorov MG, Smirnova E, Bos PD, Rutkowski MR. Pre-existing commensal dysbiosis is a host-intrinsic regulator of tissue inflammation and tumor cell dissemination in hormone receptor-positive breast cancer. Cancer Research. PMID 31064848 DOI: 10.1158/0008-5472.Can-18-3464  0.56
2019 Clark NM, Bos PD. Tumor-Associated Macrophage Isolation and In Vivo Analysis of Their Tumor-Promoting Activity. Methods in Molecular Biology (Clifton, N.J.). 1884: 151-160. PMID 30465201 DOI: 10.1007/978-1-4939-8885-3_10  0.465
2019 Du W, Martinez L, Robila V, Clark N, Idowu M, Bos P. Abstract 5031: Regulatory T cell ablation accelerates early stage breast cancer progression Cancer Research. 79: 5031-5031. DOI: 10.1158/1538-7445.Am2019-5031  0.57
2016 Plitas G, Konopacki C, Wu K, Bos PD, Morrow M, Putintseva EV, Chudakov DM, Rudensky AY. Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer. Immunity. 45: 1122-1134. PMID 27851913 DOI: 10.1016/J.Immuni.2016.10.032  0.533
2016 Bos PD. TREG Cells in Cancer: Beyond Classical Immunological Control. Immunological Investigations. 1-8. PMID 27759466 DOI: 10.1080/08820139.2016.1222206  0.456
2016 Hu W, Arpaia N, Bos PD, Green J, Rudensky A. Abstract B081: Tissue repair function of regulatory T cells during infection and cancer progression Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-B081  0.459
2013 Bos PD, Plitas G, Rudra D, Lee SY, Rudensky AY. Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy. The Journal of Experimental Medicine. 210: 2435-66. PMID 24127486 DOI: 10.1084/Jem.20130762  0.436
2012 Bos PD, Rudensky AY. Treg cells in cancer: a case of multiple personality disorder. Science Translational Medicine. 4: 164fs44. PMID 23241741 DOI: 10.1126/Scitranslmed.3005283  0.403
2010 Bos PD, Nguyen DX, Massagué J. Modeling metastasis in the mouse. Current Opinion in Pharmacology. 10: 571-7. PMID 20598638 DOI: 10.1016/J.Coph.2010.06.003  0.606
2009 Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, Minn AJ, van de Vijver MJ, Gerald WL, Foekens JA, Massagué J. Genes that mediate breast cancer metastasis to the brain. Nature. 459: 1005-9. PMID 19421193 DOI: 10.1038/Nature08021  0.606
2009 Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization. Nature Reviews. Cancer. 9: 274-84. PMID 19308067 DOI: 10.1038/Nrc2622  0.574
2008 Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massagué J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 451: 147-52. PMID 18185580 DOI: 10.1038/Nature06487  0.643
2007 Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C, Gomis RR, Manova-Todorova K, Massagué J. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature. 446: 765-70. PMID 17429393 DOI: 10.1038/Nature05760  0.668
2007 Minn AJ, Gupta GP, Padua D, Bos P, Nguyen DX, Nuyten D, Kreike B, Zhang Y, Wang Y, Ishwaran H, Foekens JA, van de Vijver M, Massagué J. Lung metastasis genes couple breast tumor size and metastatic spread. Proceedings of the National Academy of Sciences of the United States of America. 104: 6740-5. PMID 17420468 DOI: 10.1073/Pnas.0701138104  0.643
2005 Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massagué J. Genes that mediate breast cancer metastasis to lung. Nature. 436: 518-24. PMID 16049480 DOI: 10.1038/Nature03799  0.667
2004 Kimmelman AC, Qiao RF, Narla G, Banno A, Lau N, Bos PD, Nuñez Rodriguez N, Liang BC, Guha A, Martignetti JA, Friedman SL, Chan AM. Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6. Oncogene. 23: 5077-83. PMID 15064720 DOI: 10.1038/Sj.Onc.1207662  0.334
Low-probability matches (unlikely to be authored by this person)
2015 Lu LF, Gasteiger G, Yu IS, Chaudhry A, Hsin JP, Lu Y, Bos PD, Lin LL, Zawislak CL, Cho S, Sun JC, Leslie CS, Lin SW, Rudensky AY. A Single miRNA-mRNA Interaction Affects the Immune Response in a Context- and Cell-Type-Specific Manner. Immunity. 43: 52-64. PMID 26163372 DOI: 10.1016/J.Immuni.2015.04.022  0.283
2013 Gasteiger G, Hemmers S, Bos PD, Sun JC, Rudensky AY. IL-2-dependent adaptive control of NK cell homeostasis. The Journal of Experimental Medicine. 210: 1179-87. PMID 23650439 DOI: 10.1084/Jem.20122571  0.281
2021 Mondal T, Shivange GN, Tihagam RG, Lyerly E, Battista M, Talwar D, Mosavian R, Urbanek K, Rashid NS, Harrell JC, Bos PD, Stelow EB, Stack MS, Bhatnagar S, Tushir-Singh J. Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies. Embo Molecular Medicine. e12716. PMID 33587338 DOI: 10.15252/emmm.202012716  0.275
2023 van der Hulst HJ, Jansen RW, Vens C, Bos P, Schats W, de Jong MC, Martens RM, Bodalal Z, Beets-Tan RGH, van den Brekel MWM, de Graaf P, Castelijns JA. The Prediction of Biological Features Using Magnetic Resonance Imaging in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Cancers. 15. PMID 37894447 DOI: 10.3390/cancers15205077  0.267
2022 Hong EK, Bodalal Z, Landolfi F, Bogveradze N, Bos P, Park SJ, Lee JM, Beets-Tan R. Identifying high-risk colon cancer on CT an a radiomics signature improve radiologist's performance for T staging? Abdominal Radiology (New York). PMID 35661244 DOI: 10.1007/s00261-022-03534-0  0.226
2022 Rodríguez Outeiral R, Bos P, van der Hulst HJ, Al-Mamgani A, Jasperse B, Simões R, van der Heide UA. Strategies for tackling the class imbalance problem of oropharyngeal primary tumor segmentation on magnetic resonance imaging. Physics and Imaging in Radiation Oncology. 23: 144-149. PMID 36035088 DOI: 10.1016/j.phro.2022.08.005  0.215
2021 Rodríguez Outeiral R, Bos P, Al-Mamgani A, Jasperse B, Simões R, van der Heide UA. Oropharyngeal primary tumor segmentation for radiotherapy planning on magnetic resonance imaging using deep learning. Physics and Imaging in Radiation Oncology. 19: 39-44. PMID 34307917 DOI: 10.1016/j.phro.2021.06.005  0.215
2023 Su T, Zhou S, Yang S, Humble N, Zhang F, Yu G, Bos PD, Cheng F, Valerie K, Zhu G. Lymph node-targeting adjuvant/neoantigen-codelivering vaccines for combination glioblastoma radioimmunotherapy. Theranostics. 13: 4304-4315. PMID 37649594 DOI: 10.7150/thno.84443  0.19
2022 Bos P, Martens RM, de Graaf P, Jasperse B, van Griethuysen JJM, Boellaard R, Leemans CR, Beets-Tan RGH, van de Wiel MA, van den Brekel MWM, Castelijns JA. External validation of an MR-based radiomic model predictive of locoregional control in oropharyngeal cancer. European Radiology. PMID 36460924 DOI: 10.1007/s00330-022-09255-8  0.165
2021 Bos P, van den Brekel MWM, Gouw ZAR, Al-Mamgani A, Taghavi M, Waktola S, Aerts HJWL, Castelijns JA, Beets-Tan RGH, Jasperse B. Improved outcome prediction of oropharyngeal cancer by combining clinical and MRI features in machine learning models. European Journal of Radiology. 139: 109701. PMID 33865064 DOI: 10.1016/j.ejrad.2021.109701  0.147
2020 Min LA, Vacher YJL, Dewit L, Donker M, Sofia C, van Triest B, Bos P, van Griethuysen JJW, Maas M, Beets-Tan RGH, Lambregts DMJ. Gross tumour volume delineation in anal cancer on T2-weighted and diffusion-weighted MRI - reproducibility between radiologists and radiation oncologists and impact of reader experience level and DWI image quality. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 32540336 DOI: 10.1016/j.radonc.2020.06.012  0.119
2023 Bos PD, Yoshimura A, Rudra D. Editorial: Non-lymphoid functions of regulatory T cells in health and disease. Frontiers in Immunology. 14: 1109245. PMID 36726687 DOI: 10.3389/fimmu.2023.1109245  0.114
2021 Bos P, van der Hulst HJ, van den Brekel MWM, Schats W, Jasperse B, Beets-Tan RGH, Castelijns JA. Prognostic functional MR imaging parameters in head and neck squamous cell carcinoma: A systematic review. European Journal of Radiology. 144: 109952. PMID 34562743 DOI: 10.1016/j.ejrad.2021.109952  0.113
2020 Bos P, van den Brekel MWM, Gouw ZAR, Al-Mamgani A, Waktola S, Aerts HJWL, Beets-Tan RGH, Castelijns JA, Jasperse B. Clinical variables and magnetic resonance imaging-based radiomics predict human papillomavirus status of oropharyngeal cancer. Head & Neck. PMID 33029923 DOI: 10.1002/hed.26505  0.095
2018 Van't Hullenaar CDP, Bos P, Broeders IAMJ. Ergonomic assessment of the first assistant during robot-assisted surgery. Journal of Robotic Surgery. 13: 283-288. PMID 30043126 DOI: 10.1007/s11701-018-0851-0  0.022
Hide low-probability matches.